NASDAQ: SLGL - Sol-Gel Technologies Ltd.

Rentabilität für sechs Monate: +21.83%
Dividendenrendite: 0.00%
Sektor: Healthcare

Aktionsplan Sol-Gel Technologies Ltd.

Erweiterter Zeitplan Einfaches Diagramm
Financial Markets by TradingView

Über das Unternehmen Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel.

weitere details
The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment of acne vulgaris; Epsolay, a once-daily topical cream that has completed Phase III clinical trials for the treatment of papulopustular rosacea; SGT-210, which is in Phase I clinical trial for the treatment of palmoplantar keratoderma; SGT-610, a rare disease for the treatment of Gorlin Syndrome which has completed Phase II clinical trials; and Erlotinib and Tapinarof to treat other rare skin indications. It is also involved in the development of generic topical dermatological drug products. The company has collaboration with Perrigo. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

IPO date 2018-01-23
ISIN IL0011417206
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.sol-gel.com
Цена ао 0.9875
Preisänderung pro Tag: -8.2% (1.22)
Preisänderung pro Woche: +161.07% (0.429)
Preisänderung pro Monat: +94.78% (0.575)
Preisänderung über 3 Monate: +64.73% (0.6799)
Preisänderung über sechs Monate: +21.83% (0.9193)
Preisänderung pro Jahr: +1.36% (1.105)
Preisänderung über 3 Jahre: -83.98% (6.99)
Preisänderung über 5 Jahre: -86.49% (8.29)
Preisänderung über 10 Jahre: 0% (1.12)
Preisänderung seit Jahresbeginn: +109.74% (0.534)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 20.92 1
P/BV 0.8411 9
P/E 0 0
EV/EBITDA -0.9182 0
Gesamt: 4.63

Effizienz

Name Bedeutung Grad
ROA, % -60.15 0
ROE, % -70.48 0
Gesamt: 0

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0 0
Gesamt: 0

Pflicht

Name Bedeutung Grad
Debt/EBITDA -0.057 10
Gesamt: 10

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % -93.21 0
Rentabilität Ebitda, % 15.39 3
Rentabilität EPS, % -20.18 0
Gesamt: 1
Weitere Details

Institutionen Volumen Aktie, %
Phoenix Holdings Ltd. 2574922 9.24
Armistice Capital, LLC 2135000 7.66
Migdal Insurance & Financial Holdings Ltd. 1227548 4.41
Harel Insurance Investments & Financial Services Ltd. 920333 3.3
Kingdon Capital Management LLC 674923 2.42
Yelin Lapidot Holdings Management Ltd. 229178 0.82
Raymond James Financial Services Advisors, Inc. 43102 0.15
Raymond James & Associates, Inc. 30915 0.11
Morgan Stanley 28935 0.1
Citadel Advisors Llc 17259 0.06



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Dr. Alon Seri-Levy Co-Founder, CEO & Director 411k 1961 (64 Jahr)
Mr. Gilad Mamlok Advisor 367k 1968 (57 Jahre)
Dr. Itzik Yosef Chief Operating Officer 236k 1976 (49 Jahre)
Mr. Moshe Arkin Executive Chairman of the Board N/A 1953 (72 Jahr)
Prof. David Avnir Co-Founder N/A
Ms. Tamar Fishman Jutkowitz VP & General Counsel N/A 1976 (49 Jahre)
Dr. Karine Neimann VP of Projects & Planning and Chief Chemist N/A 1971 (54 Jahr)
Mr. Eyal Ben-Or Chief Financial Officer

Adresse: Israel, Ness Ziona, 7 Golda Meir Street - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.sol-gel.com